Clinical trial Recruiting at 1 site Observational Ages 18 and up

Real-time vital-sign monitoring after major urologic surgery to spot complications early

Official title: Real-time Evaluation and Continuous Observation of Vital Signs for Enhanced Recovery

Run by Azienda Ospedaliero-Universitaria di Parma · NCT07729891 · Data updated 2026-11-12

Researchers are trying a wearable that continuously tracks vital signs to see if they can detect postoperative problems sooner for adults having major urologic surgery who won’t go to intensive care.

More Respiratory Complications trials

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment150 (estimated)
SponsorAzienda Ospedaliero-Universitaria di Parma
Academic / other
Locations1 site (Parma, Parma)
StatusRecruiting
StartedFebruary 10, 2026
Main results expectedFebruary 2027
Study endsFebruary 2027
Registry record updatedJuly 28, 2026
Trial IDNCT07729891 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults over 18 undergoing medium-to-high complexity urologic surgery under general anesthesia and discharged to a surgical ward.

Probably not a fit

Patients not fitting the eligibility criteria or those not requiring ward-based postoperative monitoring may not benefit from this approach.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study tests whether continuous vital-sign monitoring with the Portrait Mobile wearable can identify postoperative complications earlier than standard ward monitoring in adults recovering from major urologic surgery. It focuses on detecting changes in heart rate, breathing rate, and oxygen saturation that may indicate respiratory or hemodynamic deterioration in the first days after surgery. The study analyzes how often vital-sign changes occur and whether trends or deviations from baseline signal pending complications. Results could inform whether wireless monitoring improves early recognition of deterioration outside the intensive care setting.

Why it matters

Potential benefit: If successful, continuous monitoring could enable earlier detection of complications and faster clinical response for patients after major urologic surgery.

How similar studies have gone: Previous studies in other surgical populations have shown that continuous wearable monitoring can identify deterioration earlier than intermittent checks, though results vary by setting.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Ability to give informed consent and consent to the processing of personal data by signing the relevant forms;
* Aged over 18 years old
* Medium-to-high complexity urological surgery without the need for post-operative monitoring in the Intensive Care Unit
* Surgery performed under general anaesthesia
* Discharge to the ward is scheduled upon leaving the operating theatre

Exclusion Criteria:

* Refusal or inability to consent to participation
* Patients under 18 years old
* Planned admission to Post-Operative Intensive Care Unit after the surgery
* Unplanned admission to the Post-Operative Intensive Care Unit at the end of the surgery
* Anaesthetic technique other than general anaesthesia.

Where it's running

  • 2^ Anestesia, Rianimazione, Terapia Intensiva - Azienda Ospedaliero Universitaria di Parma
    Parma, Parma, Italy
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.